MarketCap
Facebook
X
TelegramAnnual report 2022
added 08-30-2022
Genetic Technologies Limited P/S Ratio 2011-2026 | GENE
Annual P/S Ratio Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.36 K | 142 K | 1.68 M | 605 | 138 | 32.8 | 41.6 | 16 | 5.04 | 15.7 | 20.6 | 5.89 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.68 M | 5.04 | 152 K |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
6.64 | $ 118.41 | -1.12 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 19.13 | -6.98 % | $ 206 M |  China |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 20.4 | 16.11 % | $ 1.09 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
9.4 | $ 1.44 | 1.24 % | $ 1.92 M | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 24.65 | 0.12 % | $ 685 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 182.43 | 0.98 % | $ 9.04 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
6.09 | $ 194.63 | -1.75 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
3.75 | $ 129.72 | -1.92 % | $ 20.6 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 16.11 | -0.34 % | $ 487 M | USA |
 |
Guardant Health
GH
|
13.7 | $ 85.08 | 0.26 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B |  Niderland |
 |
NeoGenomics
NEO
|
2.04 | $ 8.57 | -1.32 % | $ 1.1 B | USA |
 |
Anixa Biosciences
ANIX
|
0.718 | $ 2.88 | -1.7 % | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.12 | 0.47 % | $ 4.87 M | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 527.68 | 1.76 % | $ 15.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 116.64 | 0.12 % | $ 9.62 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 268.68 | 0.67 % | $ 22.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 29.16 | 0.31 % | $ 20 B | Niderland |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
Senseonics Holdings
SENS
|
9.94 | $ 6.79 | -1.59 % | $ 283 M | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 5.12 | -1.35 % | $ 474 M | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 84.11 | 0.2 % | $ 5.68 B | USA |
 |
Soleno Therapeutics
SLNO
|
10.9 | $ 52.65 | 0.14 % | $ 2.68 B | USA |
 |
Neuronetics
STIM
|
0.544 | $ 1.37 | -1.44 % | $ 90.4 M | USA |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.36 | -0.64 % | $ 2.03 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 193.25 | 1.0 % | $ 21.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 5.14 | - | $ 4.05 M | USA |
 |
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 17.73 | -0.62 % | $ 397 M | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 524.62 | -1.3 % | $ 198 B | USA |